Shefali Tandon Lumb is an associate in the technology transactions practice of Wilson Sonsini Goodrich & Rosati.

She advises emerging and established life sciences companies, with an emphasis on consumer health, digital health, medical device, diagnostic, pharmaceutical, biopharmaceutical, and biotechnology companies. Shefali’s practice focuses on transactions in which intellectual property assets are the key drivers, including research and development agreements; manufacturing, supply, and distribution agreements; clinical trial arrangements; materials transfer agreements; and commercialization and co-commercialization agreements. In addition, she regularly counsels clients on complex partnering and licensing arrangements, mergers, acquisitions, divestitures, spin-outs, and other business arrangements.

Prior to joining the firm, Shefali was an associate in the corporate and securities law group of Gunderson Dettmer in Redwood City, California, where she represented a wide variety of technology companies across the consumer internet, internet security, software, education, mobile communications, e-commerce, financial, and entertainment technology industries, as well as a number of top-tier venture capital firms.

In 2012, Shefali completed Level I of the Chartered Financial Analyst certification for investment management. She is fluent in Hindi.